We are live on ! Find out more
OPTR

OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR

Delisted

OPTR was delisted on the 23rd of October, 2013.

104 hedge funds and large institutions have $526M invested in OPTIMER PHARMACEUTICALS, INC. COM STK in 2013 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 34 increasing their positions, 25 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 25

9% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 33

1% more funds holding

Funds holding: 103104 (+1)

18% less capital invested

Capital invested by funds: $642M → $526M (-$116M)

74% less call options, than puts

Call options by funds: $1.84M | Put options by funds: $6.99M

Holders
104
Holders Change
+1
Holders Change %
+0.97%
% of All Funds
3.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
36
Increased
34
Reduced
25
Closed
33
Calls
$1.84M
Puts
$6.99M
Net Calls
-$5.14M
Net Calls Change
-$9.23M
Name Holding Trade Value Shares
Change
Change in
Stake
MWAM
101
Mariner Wealth Advisors (Madison)
Kansas
$4K
ST
102
Spot Trading
Illinois
$3K +$3.11K +235 New
ACM
103
Aviance Capital Management
Florida
$2K +$2.44K +184 New
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$476 -$20.3K -1,533 -4%
DM
105
Deerfield Management
New York
-$43.8M -3,025,829 Closed
GIM
106
Granahan Investment Management
Massachusetts
-$38.1M -2,636,421 Closed
PCM
107
Pentwater Capital Management
Florida
-$22.4M -1,550,000 Closed
Hudson Bay Capital Management
108
Hudson Bay Capital Management
Connecticut
-$10.3M -714,087 Closed
O
109
OrbiMed
New York
-$7.76M -536,000 Closed
AIM
110
Allen Investment Management
New York
-$7.24M -500,000 Closed
MG
111
Meditor Group
Bermuda
-$6.87M -475,000 Closed
CII
112
CR Intrinsic Investors
Connecticut
-$4.55M -314,718 Closed
TAL
113
TIG Advisors LLC
New York
-$3.9M -269,265 Closed
MWVC
114
Morgens Waterfall Vintiadis & Co
New York
-$3.69M -255,000 Closed
LCM
115
LionEye Capital Management
New York
-$2.57M -177,799 Closed
USAA
116
United Services Automobile Association
Texas
-$2.52M -174,348 Closed
WMSA
117
Weiss Multi-Strategy Advisers
New York
-$1.59M -110,000 Closed
BCM
118
BBT Capital Management
Texas
-$1.52M -105,000 Closed
SCA
119
SAC Capital Advisors
Connecticut
-$1.48M -102,560 Closed
SC
120
Sophrosyne Capital
New York
-$1.45M -100,500 Closed
UOC
121
UBS O'Connor
Illinois
-$868K -60,000 Closed
CA
122
Commerzbank Aktiengesellschaft
Germany
-$786K -54,336 Closed
LI
123
LMCG Investments
Massachusetts
-$759K -52,431 Closed
American Century Companies
124
American Century Companies
Missouri
-$749K -51,740 Closed
TRSOTSOK
125
Teachers Retirement System of the State of Kentucky
Kentucky
-$730K -50,447 Closed

OPTR Hedge Fund Activity: Q3 2013 in Review

104 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) for Q3 2013, worth a combined $526M — down 18% from $642M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new OPTR positions and 33 closed out — a net gain of 3 holders — while 34 added to existing stakes and 25 trimmed.

The largest buyer was Water Island Capital, adding an estimated $38.6M. The largest seller was Wellington Management Group, cutting an estimated $44.7M.

  • 104 institutional investors held OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) as of Q3 2013, up from 103 in Q2 2013.
  • Funds reported $526M of OPTIMER PHARMACEUTICALS, INC. COM STK stock for Q3 2013, down 18% quarter-over-quarter.
  • 36 funds opened new OPTIMER PHARMACEUTICALS, INC. COM STK positions in Q3 2013 and 33 closed out, a net change of +3 holders.
  • The largest OPTIMER PHARMACEUTICALS, INC. COM STK buyer in Q3 2013 was Water Island Capital, an estimated $38.6M added.
  • The largest OPTIMER PHARMACEUTICALS, INC. COM STK seller in Q3 2013 was Wellington Management Group, an estimated $44.7M sold.

Based on aggregated 13F filings for Q3 2013.